In regard to CNS, anti-LAG3 monoclonal antibodies are being currently investigated in the case of recurrent glioblastoma multiform, being able to cross the blood–brain barrier (Trial ID NCT02658981). This evidence concerns the gene LAG3 and glioblastoma.